CanadaBis Capital (CanadaBis Capital) EV-to-EBIT : 3.84 (As of Jun. 08, 2024)

View and export this data going back to 2023. Start your Free Trial

What is CanadaBis Capital EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CanadaBis Capital's Enterprise Value is $11.18 Mil. CanadaBis Capital's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was $2.91 Mil. Therefore, CanadaBis Capital's EV-to-EBIT for today is 3.84.

The historical rank and industry rank for CanadaBis Capital's EV-to-EBIT or its related term are showing as below:

CNADF' s EV-to-EBIT Range Over the Past 10 Years
Min: -26.02 Med: -3.28 Max: 12.91
Current: 3.91

During the past 8 years, the highest EV-to-EBIT of CanadaBis Capital was 12.91. The lowest was -26.02. And the median was -3.28.

CNADF's EV-to-EBIT is ranked better than
92.53% of 669 companies
in the Drug Manufacturers industry
Industry Median: 16.7 vs CNADF: 3.91

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. CanadaBis Capital's Enterprise Value for the quarter that ended in Jan. 2024 was $33.64 Mil. CanadaBis Capital's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was $2.91 Mil. CanadaBis Capital's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 8.65%.

CanadaBis Capital EV-to-EBIT Historical Data

The historical data trend for CanadaBis Capital's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital EV-to-EBIT Chart

CanadaBis Capital Annual Data

Trend

Nov16

Dec17

Dec18

Jul19

Jul20

Jul21

Jul22

Jul23

EV-to-EBIT

Get a 7-Day Free Trial

-4.39

-6.39

-11.12

11.41

8.83

CanadaBis Capital Quarterly Data
	Mar19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-EBIT	Get a 7-Day Free Trial															5.73	9.68	8.83	7.20	9.25

Competitive Comparison of CanadaBis Capital's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanadaBis Capital's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's EV-to-EBIT falls into.

CanadaBis Capital EV-to-EBIT Calculation

CanadaBis Capital's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	11.177	/	2.91
	=	3.84

CanadaBis Capital's current Enterprise Value is $11.18 Mil.
CanadaBis Capital's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.91 Mil.

CanadaBis Capital (OTCPK:CNADF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

CanadaBis Capital's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jan. 2024 )	=	EBIT	/	Enterprise Value (Q: Jan. 2024 )
	=	2.91	/	33.63532
	=	8.65 %

CanadaBis Capital's Enterprise Value for the quarter that ended in Jan. 2024 was $33.64 Mil.
CanadaBis Capital's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.91 Mil.

CanadaBis Capital EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

CanadaBis Capital (CanadaBis Capital) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (OTCPK:CNADF) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

CANB:Canada

Address

PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6

Website

https://www.canadabis.com

CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.